Moderna completes application to u.s. food and drug administration for emergency use authorization of omicron-targeting bivalent covid-19 booster vaccine, mrna-1273.222
Mrna-1273.222 targets ba.4/ba.5 strains of omicron variant pending authorization, moderna ready to ship bivalent booster mrna-1273.222 in september clinical data available for moderna's bivalent covid-19 booster vaccines have met all primary endpoints and support request for emergency use authorization cambridge, ma / accesswire / august 23, 2022 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced that it has completed its submission to the u.s. food and drug administration (fda) for emergency use authorization for its ba.4/ba.5 omicron-targeting bivalent covid-19 booster vaccine, mrna-1273.222. the application is for a 50 Μg booster dose for adults 18 years of age and older, and is based on preclinical data as well as clinical trial data available for the company's ba.1 omicron-targeting bivalent booster candidate, mrna-1273.214.
MRNA Ratings Summary
MRNA Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission